Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.550
+0.140 (3.17%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $279.87 million as of April 17, 2025. Its market cap has decreased by -19.45% in one year.
Market Cap
279.87M
Enterprise Value
-49.56M
1-Year Change
-19.45%
Ranking
Category
Stock Price
$4.55
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $279.87M, a decrease of -66.89%. That is a compound annual growth rate of -25.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 279.87M | -34.36% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| UnitedHealth Group | 533.82B |
| Johnson & Johnson | 370.25B |
| AbbVie | 312.76B |
| Novo Nordisk | 286.28B |
| Abbott Laboratories | 218.91B |
| AstraZeneca | 210.97B |
| Novartis AG | 209.02B |